Journals / Van Sağlık Bilimleri Dergisi / 2000 / Cilt: 6 Sayı: 1-2 - 2000

Erythropoietin: Structure, productioıı site, metabolism, meclıanism of effect and measurement

Eritropoietin: Yapısı, yapım yeri, metabolizması, etki mekanizması ve ölçüm metotları

Pages
142–147
Publication Date
2000-06-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

İn this review, it has been given some information about the structure of Epo, pıoduction site, effect and mechanism and, assay methods of it which is used a diagnostic tool in kidney diseases and anemi as

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Erythropoietin Epo is a glycoprotein hormone which functions as a gıowth factor for stimulating the proliferation and differentiation of erythroid precusor cells.
📊
Key Findings & Data:The hormone is produced primarily by the kidney.
💡
Conclusion & Impact:İn this review, it has been given some information about the structure of Epo, pıoduction site, effect and mechanism and, assay methods of it which is used a diagnostic tool in kidney diseases and anemi as
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Eritropoietin. Eritropoietinin mekanizması ve ölçüm metotları · Erythropoietin · Mechanism and clinical use of erythropoietin.

Abstract

Erythropoietin Epo is a glycoprotein hormone which functions as a gıowth factor for stimulating the proliferation and differentiation of erythroid precusor cells. The hormone is produced primarily by the kidney. Epo can be measured with bioassay, which determine the hormone’s activity, or with immunoassay, which detect the Epo antigen. To determine the level of Epo, serum, plasma and urine can be used. İn this review, it has been given some information about the structure of Epo, pıoduction site, effect and mechanism and, assay methods of it which is used a diagnostic tool in kidney diseases and anemi as

Özet

Eritropoietin Epo , glikoprotein yapısında bir hormon olup, eritroid seri ön hücrelerin çoğalmasını ve olgunlaşmasını sağlar. Başlıca üretim yeri böbreklerdir. Epo, Epo aktivitesini tespit eden bioassaylerle veya Epo antijenini belirleyen immunoassaylerle ölçülebilmektedir. Epo seviyesini belirlemek için serum, plazma ve idrar kullanılmaktadır. Bu derlemede, böbrek hastalıkları ve anemide tanı kriteri olarak kullanılan eritropoietinin yapısı, yapım yeri, etki yeri ve mekanizması ile ölçüm metotları hakkındaki bilgiler aktarılmaya çalışılmıştır

🔖

Cite This Article

CEYLAN, E. (2000). Erythropoietin: Structure, productioıı site, metabolism, meclıanism of effect and measurement. Van Sağlık Bilimleri Dergisi, Cilt: 6 Sayı: 1-2 - 2000, 142–147. https://ajindex.com/articles/953050

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Woodman DD: Erythropoietin, Comparative Haematology International 2: 1-7,(1992)
  2. Ceylan E: Köpeklerde deneysel nefrotoksikozisde eritropoietin seviyesi ve bazı hematolojik parametreler üzerine araştırmalar. Yüzüncü Yıl Üniv., Sağlık Bilimleri Enstitüsü, Doktora Tezi, (1998)
  3. Spivak JL,Watson AJ: Hematopoiesis and the Kidney The Kidney: Physiology and Patophysiology. Second Ed. Raven Press, Ltd., New York, Chapter42: 1553-1593, (1992)
  4. Fu JS, Leriora JJL, Rice JC, Fisher JW: Pharmacokinetics of erythropoietin in intact and anephric dogs. J. Lab. Clin Med. 111:669-676,(1983)
  5. Erslev AJ: Erythropoietin, The New England Journal of Medicine, 324(19): 1339-1344, (1991)
  6. Caro J, Erslev AJ: Erythropoietin assays and their use in the study of anemias. Contrib. Nephrol. 66: 54, (1988)
  7. Giger U: Erythropoietin and its Clinical Use, Comp. Continuing Education Article 14(1): 25-34, (1992)
  8. Krantz SB: Erythropoietin. Blood, 77(3): 419-434, (1991)
  9. Miyake T, Kung CKH. Goldwasser E: Purifıcation of human erythropoietin. J. Biol. Chem. 252: 5558-5564, (1977)
  10. Dordal MS, Wang F.F, Goldwasser E: The role of carbohydrate in erythropoietin aetion. Endocrinology. 116: 2293, (1985)
  11. Browne JK, Cohen AM, Egrie JC, Lai PH, Lin FK, Strickland T, Watson E, Stebbing N: Erythropoietin, Gene eloning protein strueture, and biological properties. Cold Spring Harbor Symp Quant Biol. 51:693-702, (1986)
  12. Goldwasser E, Kung CHK, Eliason J: On the mechanism of erythropoietin-induced differenciation. XIII. The role of sialic acid in erythropoietin aetion. J Biol. Chem 249: 4202, (1974)
  13. Spivak JL, Hogans BB: The in vivo metabolism of recombinant human erytropoietin in the rat. Blood. 73: 90-99, (1989)
  14. Wang FF, Kung CKH, Golvvasser E: Some Chemical properties of human erythropoietin. Endocrinology 1116: 2286, (1985)
  15. Cotes PM, Bangham DR: The international reference preparation of erythropoietin. Bull WHO 35: 751, (1966)
  16. Annable L, Cotes PM, Mussett MV: The second international reference preparation of erythropoietin, human, urinary, for bioassay. Bull. Org. Mond. Sante 47: 99-112, (1972)
  17. Fried W, Barone-Varelas J, Morley C: Factors that regulate extrarenal erythropoietin produetion. Blood Cells 10:287, (1984)
  18. Naughton BA, Bimbach DL, Lıu P et al.: Erythropoietin produetion and kupffer celi alterations following nephrectomy, hypoxia, or combined nephrectomy and hypoxia. Proc. Soc. Exp. Biol. Med. 160: 170-174, (1979)
  19. Koury